Drug therapy of arterial hypertension: assessment of the senior students’ basic knowledge. Final results of the PHYSTARH project

Author:

Bontsevich R. A.1ORCID,Vovk Ya. R.2ORCID,Kotlyarova V. K.3ORCID,Batishcheva G. A.4ORCID,Goncharova N. Y.5ORCID,Cherenkova O. V.5ORCID,Ketova G. G.ORCID,Barysheva V. O.6ORCID,Bikkinina G. M.7ORCID

Affiliation:

1. Belgorod State National Research University; LLC Children's medical center “Azbuka zdorovya”

2. Kursk State Medical University; LLC “MedLine”

3. Belgorod State National Research University

4. Belgorod State National Research University; Voronezh State Medical University named after N.N. Burdenko

5. Voronezh State Medical University named after N.N. Burdenko

6. The National Medical Research Center for Endocrinology

7. Bashkir State Medical University

Abstract

Introduction. Arterial hypertension (AH) is the main correctable cause of the development of cardiovascular diseases, leading to dysfunction of many organs, including the heart, blood vessels and kidneys. Lack of adequate control of systolic and/or diastolic blood pressure can lead to life-threatening conditions and death.The aim of study is to analyze the senior medical students’ knowledge from different regions of Russia in the basic issues of hypertension therapy.Materials and methods. The article presents the results of the first stage of the PHYSTARH multicenter study (the full name of the project is Physicians’ and undergraduates’ knowledge in arterial hypertension treatment): an anonymous survey among 285 senior medical students from 4 cities of Russia. In this article, the authors analyzed the questions of the second part of the questionnaire.Results. The average level of correct answers on the questionnaire was 57.7%. The minimum level of correct answers was obtained in questions about the effectiveness of combined therapy, as well as the choice of absolute contraindications to the use of antihypertensive drugs. The maximum level of correct answers was registered in the question about determining the drug to its pharmacological group.Conclusion. The obtained results testify to the insufficiently level of students’ knowledge in the basic issues of arterial hypertension therapy.

Publisher

Intermedservice Ltd

Reference18 articles.

1. Global Health Estimates: Life expectancy and leading causes of death and disability // THE GLOBAL HEALTH OBSERVATORY URL: https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates (дата обращения: 18.05.2021).

2. NCD Risk Factor Collaboration (NCD-RisC) Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet. 2021; 398(10304):957-980. https://doi.org/10.1016/S0140-6736(21)01330-1

3. Bontsevich R, Chernykh A, Leonova A, et al. Physicians’ and undergraduates’ knowledge of drugs contraindicated for arterial hypertension treatment. Eur J Clin Pharmacol. 2019;75(Suppl. 1):S28(EACPT1241). The Abstracts: 14th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT). 29 June — 2 July 2019, Stockholm, Sweden. https://doi.org/10.1007/s00228-019-02685-2

4. Bontsevich RA, Vovk YaR, Gavrilova AA, et al. Physicians’ and senior medical students’ knowledge of drugs contraindicated for arterial hypertension treatment according to the PHYSTARH study. Sys Rev Pharm. 2020;11(6):26-30. https://doi.org/10.31838/srp.2020.6.06

5. Bontsevich R.A., Vovk Y.R., Gavrilova A.A., Kirichenko A.A., Krotkova I.F., Kosmacheva E.D., Kompaniets O.G., Prozorova G.G., Nevzorova V.A., Martynenko I.M., Ketova G.G., Barysheva V.O., Maksimov M.L., Osipova O.A. Drug therapy of arterial hypertension: assessment of the physicians’ basic knowledge. Final results of the PHYSTARH project. Systemic Hypertension. 2021;18(2):80-87. (in Russ.) https://doi.org/10.26442/2075082X.2021.2.200884

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3